ABCT Participant Directory

Choukri Ben Mamoun

YSM10018_0578_C_Ben Mamoun

EliV5 Therapeutics

2019

Affiliations

Yale University

Technologies

Therapeutic

Indication

Basic Research

Drug Discovery

Infectious Disease

Executive Summary

View/Download

Website

www.eliv5therapeutics.com

EliV5 Therapeutics aims to develop a new class of antifungal drugs that target a critical step in fungal metabolism required for pathogen survival and virulence.

Contact ABCT

Newsletter Signup

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Corporate Supporters

For more information about Corporate Support and Community Service Provider Support, please contact our Senior Program Manager, Maggie El Naamani at maggie@firstxfounder.com

Program of

Initiated by